Perrigo (PRGO) Liabilities from Discontinued Operations (2020 - 2026)
Perrigo's (PRGO) quarterly Liabilities from Discontinued Operations came in at 28900000.0 in Q1 2026, up 542.22% year-on-year from 4500000.0 in Q1 2025, and up 7.84% on a QoQ basis from 26800000.0 in Q4 2025.
Perrigo (PRGO) Liabilities from Discontinued Operations (2020 - 2026) Analysis & Trends
Perrigo (PRGO) has 5 years of Liabilities from Discontinued Operations data on file, last reported at 28900000.0 in Q1 2026.
- On a quarterly basis, Liabilities from Discontinued Operations rose 542.22% year-over-year to 28900000.0 in Q1 2026; TTM through Mar 2026 was 28900000.0, a 542.22% increase from a year earlier, with the FY2025 full-year figure at 26800000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q1 2026 stood at 28900000.0, up from 26800000.0 in the prior quarter.
- Over the last five years, Liabilities from Discontinued Operations for PRGO reached as high as 51500000.0 in Q2 2024 and fell as low as 4500000.0 in Q1 2025.
- Historically, Liabilities from Discontinued Operations has averaged 26216666.67 across 3 years, with a median of 27850000.0 in 2025.
- Across the five-year window, Liabilities from Discontinued Operations jumped 356.1% in 2025 and jumped 542.22% in 2026, its largest moves.
- Year by year, Liabilities from Discontinued Operations stood at 8200000.0 in 2024, then jumped by 226.83% to 26800000.0 in 2025, then increased by 7.84% to 28900000.0 in 2026.
- Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were 28900000.0 in Q1 2026, 26800000.0 in Q4 2025, and 37400000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 28.90 Mn |
| Mar 28, 2026 | 28.90 Mn |
| Dec 31, 2025 | 26.80 Mn |
| Dec 31, 2025 | 26.80 Mn |
| Sep 27, 2025 | 37.40 Mn |
| Sep 27, 2025 | 37.40 Mn |
| Mar 29, 2025 | 4.50 Mn |
| Mar 29, 2025 | 4.50 Mn |
| Sep 28, 2024 | 8.20 Mn |
| Sep 28, 2024 | 8.20 Mn |
| Jun 29, 2024 | 51.50 Mn |
| Jun 29, 2024 | 51.50 Mn |
| Dec 31, 2021 | 32.90 Mn |
| Dec 31, 2021 | 32.90 Mn |
| Oct 2, 2021 | 29.20 Mn |
| Oct 2, 2021 | 29.20 Mn |
| Jul 3, 2021 | 468.30 Mn |
| Jul 3, 2021 | 468.30 Mn |
| Apr 3, 2021 | 450.00 Mn |
| Apr 3, 2021 | 450.00 Mn |